icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow
23-26 October 2016
Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
HIV-1 Attachment Inhibitor Prodrug BMS-663068 [GSK3684934 (formerly BMS-663068)] in Antiretroviral-Experienced Subjects: Week 96 Subgroup Analysis
 
 
  HIV Glasgow 2016 Oct 23-26
 
Enrique Rafael Granados-Reyes,1 Louis Sloan,2 Jerome Ernst,3 Mey León,4 David A Stock,5 Cyril Llamoso,6
Samit R Joshi,6 George J Hanna,7 Max Lataillade6 for the AI438011 study team 1Centro de Investigación Clinica Gramel S.C, Mexico City, Mexico; 2North Texas Infectious Diseases Consultants, TX, USA;
3AIDS Community Research Initiative of America, NY, USA; 4Asociación Civil IMPACTA Salud y Educación, Lima, Peru;
5Bristol-Myers Squibb, Wallingford, CT, USA; 6ViiV Healthcare, Wallingford, CT, USA; 7Bristol-Myers Squibb, Princeton, NJ, USA
 
CROI /2016: Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 96 Analysis
http://www.natap.org/2016/CROI/croi_44.htm

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6

HIV7